
ProofPilot’s Lauren Briggs talks on why sponsors and CROs fail at tech rollouts by skipping change management, and pushes for the industry to judge trial technology by real workflow impact rather than feature checklists.
Whitepaper that examines the characteristics of various FSP models and how they help bring new therapies to market faster while remaining cost-effective.






